1
|
Mao Y, Yang D, He J and Krasna MJ:
Epidemiology of lung cancer. Surg Oncol Clin N Am. 25:439–445.
2016. View Article : Google Scholar
|
2
|
Zheng RS, Sun KX, Zhang SW, Zeng HM, Zou
XN, Chen R, Gu XY, Wei WW and He J: Report of cancer epidemiology
in China, 2015. Zhonghua Zhong Liu Za Zhi. 41:19–28. 2019.(In
Chinese).
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar
|
4
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Ares LP: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar
|
5
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar
|
6
|
Xia T, Chen S, Jiang Z, Shao Y, Jiang X,
Li P, Xiao B and Guo J: Long noncoding RNA FER1L4 suppresses cancer
cell growth by acting as a competing endogenous RNA and regulating
PTEN expression. Sci Rep. 5:134452015. View Article : Google Scholar
|
7
|
Meng Q, Ren M, Li Y and Song X:
LncRNA-RMRP acts as an oncogene in lung cancer. PLoS One.
11:e01648452016. View Article : Google Scholar
|
8
|
Guo F, Cao Z, Guo H and Li S: The action
mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell
lung cancer by regulating wnt signaling pathway. Exp Ther Med.
15:4885–4889. 2018.
|
9
|
Wang F, Chen JG, Wang LL, Yan ZZ, Chen SP
and Wang XG: Up-Regulation of LINC00346 inhibits proliferation of
non-small cell lung cancer cells through mediating JAK-STAT3
signaling pathway. Eur Rev Med Pharmacol Sci. 21:5135–5142.
2017.
|
10
|
Zhang E, Li W, Yin D, De W, Zhu L, Sun S
and Han L: C-Myc-Regulated long non-coding RNA H19 indicates a poor
prognosis and affects cell proliferation in non-small-cell lung
cancer. Tumour Biol. 37:4007–4015. 2016. View Article : Google Scholar
|
11
|
Wu J, Huang J, Wang W, Xu J, Yin M, Cheng
N and Yin J: Long non-coding RNA fer-1-like protein 4 acts as a
tumor suppressor via miR-106a-5p and predicts good prognosis in
hepatocellular carcinoma. Cancer Biomark. 20:55–65. 2017.
View Article : Google Scholar
|
12
|
Wang X, Dong K, Jin Q, Ma Y, Yin S and
Wang S: Upregulation of lncRNA FER1L4 suppresses the proliferation
and migration of the hepatocellular carcinoma via regulating
PI3K/AKT signal pathway. J Cell Biochem. 120:6781–6788. 2019.
View Article : Google Scholar
|
13
|
Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F
and Yan D: Long non-coding RNA fer-1-like protein 4 suppresses
oncogenesis and exhibits prognostic value by associating with
miR-106a-5p in colon cancer. Cancer Sci. 106:1323–1332. 2015.
View Article : Google Scholar
|
14
|
Liu Z, Shao Y, Tan L, Shi H, Chen S and
Guo J: Clinical significance of the low expression of FER1L4 in
gastric cancer patients. Tumour Biol. 35:9613–9617. 2014.
View Article : Google Scholar
|
15
|
Fei D, Zhang X, Liu J, Tan L, Xing J, Zhao
D and Zhang Y: Long noncoding RNA FER1L4 suppresses tumorigenesis
by regulating the expression of PTEN targeting miR-18a-5p in
osteosarcoma. Cell Physiol Biochem. 51:1364–1375. 2018. View Article : Google Scholar
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
17
|
Wu J, Li L, Wang Y, Ren X, Lin K and He Y:
The HSP90/AKT pathway may mediate artemether-induced apoptosis of
Cal27 cells. FEBS Open Bio. 9:1726–1733. 2019. View Article : Google Scholar
|
18
|
Zhang LX, Ding F, Wang CQ, Bing Q, Zhao Z,
Wang J and Zhang L: MiR-181a affects myocardial
ischemia-reperfusion injury in rats via regulating akt signaling
pathway. Eur Rev Med Pharmacol Sci. 23:6292–6298. 2019.
|
19
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 world health organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar
|
20
|
Li Y, Wang Z, Shi H, Li H, Li L, Fang R,
Cai X, Liu B, Zhang X and Ye L: HBXIP and LSD1 scaffolded by lncrna
hotair mediate transcriptional activation by c-myc. Cancer Res.
76:293–304. 2016. View Article : Google Scholar
|
21
|
Qi F, Liu X, Wu H, Yu X, Wei C, Huang X,
Ji G, Nie F and Wang K: Long noncoding AGAP2-AS1 is activated by
SP1 and promotes cell proliferation and invasion in gastric cancer.
J Hematol Oncol. 10:482017. View Article : Google Scholar
|
22
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar
|
23
|
Pan C, Yao G, Liu B, Ma T, Xia Y, Wei K,
Wang J, Xu J, Chen L and Chen Y: Long noncoding RNA FAL1 promotes
cell proliferation, invasion and epithelial-mesenchymal transition
through the PTEN/AKT signaling axis in non-small cell lung cancer.
Cell Physiol Biochem. 43:339–352. 2017. View Article : Google Scholar
|
24
|
Lu Q, Shan S, Li Y, Zhu D, Jin W and Ren
T: Long noncoding RNA SNHG1 promotes non-small cell lung cancer
progression by up-regulating MTDH via sponging miR-145-5p. FASEB J.
32:3957–3967. 2018. View Article : Google Scholar
|
25
|
Xia L, Nie D, Wang G, Sun C and Chen G:
FER1L4/miR-372/E2F1 works as a ceRNA system to regulate the
proliferation and cell cycle of glioma cells. J Cell Mol Med.
23:3224–3233. 2019. View Article : Google Scholar
|
26
|
Qiao Q and Li H: LncRNA FER1L4 suppresses
cancer cell proliferation and cycle by regulating PTEN expression
in endometrial carcinoma. Biochem Biophys Res Commun. 478:507–512.
2016. View Article : Google Scholar
|
27
|
Ma L, Zhang L, Guo A, Liu LC, Yu F, Diao
N, Xu C and Wang D: Overexpression of FER1L4 promotes the apoptosis
and suppresses epithelial-mesenchymal transition and stemness
markers via activating PI3K/AKT signaling pathway in osteosarcoma
cells. Pathol Res Pract. 215:1524122019. View Article : Google Scholar
|
28
|
Sun X, Zheng G, Li C and Liu C: Long
noncoding RNA fer1like family member 4 suppresses hepatocellular
carcinoma cell proliferation by regulating PTEN in vitro and
in vivo. Mol Med Rep. 19:685–692. 2019.
|
29
|
Wang Z and Li C, Li Y, Guo X, Yan Z, Gao F
and Li C: DpdtbA-Induced growth inhibition in human esophageal
cancer cells involved inactivation of the p53/EGFR/AKT pathway.
Oxid Med Cell Longev. 2019:54146702019. View Article : Google Scholar
|
30
|
Han Z, Chen F, Ge X, Tan J, Lei P and
Zhang J: MiR-21 alleviated apoptosis of cortical neurons through
promoting PTEN-Akt signaling pathway in vitro after experimental
traumatic brain injury. Brain Res. 1582:12–20. 2014. View Article : Google Scholar
|
31
|
Chen J: The cell-cycle arrest and
apoptotic functions of p53 in tumor initiation and progression.
Cold Spring Harb Perspect Med. 6:a0261042016. View Article : Google Scholar
|
32
|
Gao X, Wang N, Wu S, Cui H, An X and Yang
Y: Long noncoding RNA FER1L4 inhibits cell proliferation and
metastasis through regulation of the PI3K/AKT signaling pathway in
lung cancer cells. Mol Med Rep. 20:182–190. 2019.
|